Abstract
Effects of the antipsychotics risperidone and clozapine on 5-HT2 and D2-dopamine receptor binding were examined using [3H]N-methylspiperone ([3H]NMSP) and in vitro receptor autoradiography on human whole hemisphere cryosections. The 5-HT2 receptor antagonist ketanserin and the D2-dopamine receptor antagonist raclopride were used as references. [3H]NMSP binding was observed in caudate nucleus, putamen, and cerebral cortex indicating binding to D2-dopamine and 5-HT2 receptors. Risperidone and clozapine counteracted the binding to both receptor types. This was in contrast to raclopride, which selectively blocked the D2-dopamine receptors in the basal ganglia, and ketanserin, which selectively blocked the 5-HT2 receptors in the cerebral cortex. Risperidone (100 nM and 10 microM) blocked up to 90% of [3H]NMSP binding to both receptor types, whereas the blocking capacity of clozapine (10 microM) was lower (approximately 60%). The lack of total blockade of D2-dopamine receptors is in line with results obtained in with [11C]raclopride and positron emission tomography studies of clozapine treated human subjects. However, autoradiographic studies of clozapine competition of [3H]raclopride binding show total displacement of the binding at...Continue Reading
References
Jun 24, 1976·Nature·P SeemanK Wong
Apr 1, 1992·Acta Psychiatrica Scandinavica·A ClausS Heylen
Feb 17, 1992·Neuroscience Letters·H HallG Sedvall
Apr 18, 1991·Nature·H H Van TolO Civelli
Jan 1, 1991·Journal of Neuroscience Methods·A PerssonG Sedvall
Jan 1, 1990·Life Sciences·P B Hicks
Oct 23, 1989·Brain Research·A SchotteJ E Leysen
Jan 1, 1986·Journal of Neurochemistry·T H AndreeH Y Meltzer
Jan 1, 1986·Psychopharmacology·S O OgrenS E Sjöstrand
Jan 1, 1988·Journal of Neural Transmission·H HallG Sedvall
Mar 9, 1987·Life Sciences·J J FrostH N Wagner
Jul 1, 1985·Biochemical Pharmacology·C KöhlerL Gawell
Dec 1, 1973·Biochemical Pharmacology·Y Cheng, W H Prusoff
Jan 1, 1993·Psychopharmacology·S NybergB Eriksson
Dec 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·H HallL Farde
Jan 1, 1993·Psychopharmacology·A L NordströmC Halldin
Feb 15, 1993·Biological Psychiatry·A L NordströmG Uppfeldt
Citations
Oct 25, 2000·Synapse·H HallG Sedvall
Mar 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M M MarcusT H Svensson
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yung-Chieh YenMian-Yoon Chong
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Philip HeiserHelmut Vedder
Mar 1, 1997·Journal of Psychiatric Research·J N JoyceE V Gurevich
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·M Rodríguez-AriasJ Miñarro
Oct 17, 1998·Pharmacology & Therapeutics·B L RothW K Kroeze
Dec 1, 1996·Epilepsy Research·J R StevensP Szot
Oct 1, 1998·Psychiatry Research·G HagbergB Långström
Sep 22, 2010·The Journal of Biological Chemistry·Hirokazu YagiRobert K Yu
Jan 14, 2009·Neuropharmacology·Michail LeventopoulosJolanta Opacka-Juffry
Mar 1, 1997·Biological Psychiatry·N SudoC Kubo
Oct 17, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mary V Seeman, Philip Seeman
Oct 12, 2004·Neurotoxicology·Brian D Armstrong, Kevin K Noguchi
Feb 12, 1998·Synapse·P SvenningssonB B Fredholm
Jul 22, 2004·Synapse·Pedro Rosa-NetoPaul Cumming
Sep 29, 2000·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·H AbeK Ikebuchi
Aug 17, 2021·Journal of Clinical Pharmacology·James R Docherty, Hadeel A Alsufyani